O

OriginCell

Biotech & Life Sciences · Tangshan City, China · Founded 2014

Shanghai OriginCell Biological Cryo Equipment Co., Ltd. operates as a specialized subsidiary of the OriginCell Technology Group, focusing on the biomedical equipment sector. The company was established in 2017, incubated by its parent group, which was co-founded in 2014 by veteran entrepreneur Mr. Qu Jianguo and the publicly listed company Canature Health (300272). Mr. Qu, a notable figure who has successfully founded two other listed companies, serves as the Chairman and Chief Engineer of OriginCell, channeling his extensive entrepreneurial experience into the life sciences field. His journey began with founding a township enterprise in 1973 and later establishing 'Shenhua Industrial', one of the first eight companies listed on the A-share market. In 2014, he ventured into the health industry by founding the OriginCell Technology Group. The firm's core business revolves around the research, development, design, and manufacturing of advanced automated cryogenic storage equipment for biological samples. This addresses the critical need for reliable and efficient cryopreservation in the biomedical industry. The business model integrates hardware manufacturing with comprehensive service provisions, offering clients holistic solutions for their biobanking needs. Revenue is generated from selling this specialized equipment and providing full-process, one-stop services that include the planning, construction, management, and maintenance of biological sample and cell banks. Key clients include research hospitals, biomedical R&D enterprises, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), life science research institutions, and university medical schools. OriginCell's product portfolio is designed to create a complete, automated, and intelligent solution for the entire bio-sample lifecycle. This includes automated storage systems for both ultra-low (-80°C) and deep cryogenic (-196°C) temperatures, covering both vapor-phase and liquid-phase liquid nitrogen environments. A standout product is the BSN series, a honeycomb-style automated storage system that ensures sample safety and minimizes cross-contamination. The company also provides auxiliary equipment such as controlled-rate freezers, automated thawing systems, intelligent transport robots (AGVs/RGVs), and a 5G-IoT remote management software platform called OBS-CybeBiobank5G-IoT for unmanned, intelligent sample bank operation. This integrated approach aims to standardize and automate cryopreservation, liberating scientists from manual labor and enhancing the quality and safety of stored biological samples. Keywords: cryogenic storage equipment, automated biobanking, biological sample cryopreservation, cell bank solutions, deep cryogenic freezers, liquid nitrogen storage, laboratory automation, biomedical equipment manufacturing, Qu Jianguo, OriginCell Technology Group, intelligent sample management, whole-process biobank service, automated thawing systems, controlled-rate freezer, life science research tools, biomedical R&D support, cell therapy infrastructure, automated sample handling, cryopreservation technology